Filter Results:
(5,435)
Show Results For
- All HBS Web
(5,435)
- People (16)
- News (2,045)
- Research (2,750)
- Events (8)
- Multimedia (223)
- Faculty Publications (1,953)
Show Results For
- All HBS Web
(5,435)
- People (16)
- News (2,045)
- Research (2,750)
- Events (8)
- Multimedia (223)
- Faculty Publications (1,953)
- September 2023
- Supplement
Fighting the Battle of the Bulge—Evaluating Do Good/Do Well Innovations in Morbid Obesity Treatment
This PowerPoint accompanies Regina E. Herzlinger's "Fighting the Battle of the Bulge – Evaluating Do Good/Do Well Innovations in Morbid Obesity Treatment" teaching note (HBS Case No.324-013) and is designed for instructors to use in the classroom when teaching this... View Details
- October 2010 (Revised July 2011)
- Case
PrimedicProviding Primary Care in Mexico
By: Richard G. Hamermesh, Regina Garcia-Cuellar and Lauren Sarah Margulies
Primedic is a Mexican start-up that aims to deliver affordable primary and preventative healthcare to those at the base of the economic pyramid. The company is about to exhaust its first round of venture capital funding and the business model has yet to gain traction.... View Details
Keywords: Business Model; Business Startups; Developing Countries and Economies; Social Entrepreneurship; Venture Capital; Health Care and Treatment; Social Enterprise; Health Industry; Mexico
Hamermesh, Richard G., Regina Garcia-Cuellar, and Lauren Sarah Margulies. "PrimedicProviding Primary Care in Mexico." Harvard Business School Case 811-040, October 2010. (Revised July 2011.)
- 11 Apr 2016
- News
Professor Raffaella Sadun on Improving Care in Hospitals
- October 2017
- Case
Pricing PatientPing
By: Frank V. Cespedes, Julia Kelley and Amram Migdal
In 2017, Jay Desai, the CEO of Boston-based health care technology company PatientPing, had to consider a number of interrelated pricing challenges. Founded in late 2013, PatientPing sold a software platform that allowed health care providers to receive real-time... View Details
Keywords: Pricing; Health Tech; Health Technology; Marketing; Sales Process; Sales Strategy; Price; Sales; Marketing Strategy; Health Care and Treatment; Health Industry; Health Industry; Boston; North America; Massachusetts; United States
Cespedes, Frank V., Julia Kelley, and Amram Migdal. "Pricing PatientPing." Harvard Business School Case 818-017, October 2017.
- January 2008 (Revised August 2012)
- Case
Retail Sales of Health Insurance: Blue Cross Blue Shield of Florida
By: Regina E. Herzlinger and Grady Clouse
The BCBS of Florida is contemplating whether to enter the consumer-driven health care market and if so, whether to target such groups—and individuals—and in which of its geographic markets, and how. View Details
- January 2022
- Supplement
Somatus: Value-Based Kidney Care (B)
By: Ariel D. Stern, Robert S. Huckman and Sarah Mehta
Set in early 2020, this (B) case provides an update to the (A) case (no. 622-009) and provides additional context regarding the challenges facing Somatus. View Details
Keywords: Business Startups; Disruption; Entrepreneurship; Health; Health Care and Treatment; Health Disorders; Medical Specialties; Innovation and Invention; Disruptive Innovation; Management; Strategy; Business Strategy; Value; Value Creation; Health Industry; United States; Virginia
Stern, Ariel D., Robert S. Huckman, and Sarah Mehta. "Somatus: Value-Based Kidney Care (B)." Harvard Business School Supplement 622-045, January 2022.
- December 2009
- Article
From a Declaration of Values to the Creation of Value in Global Health
By: Jim Yong Kim, Joseph Rhatigan, Sachin H. Jain and Michael E. Porter
To make best use of the new dollars available for the treatment of disease in resource poor settings, global health practice requires a strategic approach that emphasizes value for patients, defined as health outcomes per dollar spent. Practitioners and global health... View Details
- Teaching Interest
Overview
Michaela teaches management, healthcare and research methods courses across the undergraduate, master and executive levels. Her recent courses include organizational behavior, negotiation, research in health policy, and social entrepreneurship. View Details
- Summer 2021
- Article
The Cost and Evolution of Quality at Cipla Ltd, 1935–2016
By: Muhammad H. Zaman and Tarun Khanna
This article examines the evolution of Indian pharmaceutical manufacturer Cipla towards producing drugs that met the quality standards of European and U.S. regulators. It employs new research in Cipla’s corporate archives, the Creating Emerging Markets database, and... View Details
Keywords: Cipla; Pharmaceuticals; Drug Quality; Generics; Quality; Standards; Information Technology; Cost; Organizational Culture; Business History; Pharmaceutical Industry; India
Zaman, Muhammad H., and Tarun Khanna. "The Cost and Evolution of Quality at Cipla Ltd, 1935–2016." Business History Review 95, no. 2 (Summer 2021): 249–274.
- January 2024
- Article
Cost of Exempting Sole Orphan Drugs from Medicare Negotiation
By: Matthew Vogel, Olivia Zhao, William B. Feldman, Amitabh Chandra, Aaron S. Kesselheim and Benjamin N. Rome
Importance: The Inflation Reduction Act (IRA) requires Medicare to negotiate prices for some high-spending drugs but exempts drugs approved solely for the treatment of a single rare disease.
Objective: To estimate Medicare spending and global... View Details
Objective: To estimate Medicare spending and global... View Details
Vogel, Matthew, Olivia Zhao, William B. Feldman, Amitabh Chandra, Aaron S. Kesselheim, and Benjamin N. Rome. "Cost of Exempting Sole Orphan Drugs from Medicare Negotiation." JAMA Internal Medicine 184, no. 1 (January 2024): 63–69.
- 2017
- Article
Organizational Support for Learning and Contribution to Improvement by Frontline Staff
By: Olivia Jung, Andrea Blasco and Karim R. Lakhani
Jung, Olivia, Andrea Blasco, and Karim R. Lakhani. "Organizational Support for Learning and Contribution to Improvement by Frontline Staff." Academy of Management Best Paper Proceedings (2017).
- 14 Nov 2019
- Video
Health Minute: The Real Impact of Coupons on Drug Pricing
- 03 Jan 2014
- News
This Is Not Your Parents' Health Insurance
- 04 Oct 2016
- Blog Post
Why We Recruit: CVS Health
organization.Jeff Lackey, VP Talent Acquisition, CVS Health Describe your organization in three to five sentences.CVS Health is at the forefront of a changing health View Details
Keywords: Health Care
- August 2001
- Case
Aurora Health Care: Finding "a Better Way"
By: Clayton M. Christensen and Kevin M. Dwyer
The largest hospital system in Wisconsin is trying to respond to new threats from nontraditional care providers. This case presents the hospital's dilemma as it tries to create change from within. View Details
Keywords: Change Management; Disruptive Innovation; Innovation Strategy; SWOT Analysis; Competitive Strategy; Health Industry
Christensen, Clayton M., and Kevin M. Dwyer. Aurora Health Care: Finding "a Better Way". Harvard Business School Case 602-043, August 2001.
- 2018
- Government Testimony
Health Care Industry Consolidation: What Is Happening, Why It Matters, and What Public Agencies Might Want to Do About It
By: Leemore S. Dafny
Dafny, Leemore S. "Health Care Industry Consolidation: What Is Happening, Why It Matters, and What Public Agencies Might Want to Do About It." Government Testimony, U.S. House of Representatives, Committee on Energy and Commerce, Subcommittee on Oversight and Investigations, Washington, DC, February 2018.
- 01 Mar 2012
- News
Health Care’s New Frontier
holistic health-care clinics for women became athenahealth, a $245 million enterprise that provides cloud-based practice management, billing, and electronic health record services to over 31,000 medical providers across the United States.... View Details
- 2023
- Article
Digital Health Reimbursement Strategies of 8 European Countries and Israel: Scoping Review and Policy Mapping
By: Robin van Kessel, Divya Srivastava, Ilias Kyriopoulos, Giovanni Monti, David Novillo-Ortiz, Ran Milman, Wojciech Wilhelm Zhang-Czabanowski, Greta Nasi, Ariel Dora Stern, George Wharton and Elias Mossialos
Background: The adoption of digital health care within health systems is determined by various factors, including pricing and reimbursement. The reimbursement landscape for digital health in Europe remains underresearched. Although various emergency reimbursement... View Details
Keywords: Technology Adoption; Health Care and Treatment; Cross-Cultural and Cross-Border Issues; Price; Health Industry; Europe; Israel
van Kessel, Robin, Divya Srivastava, Ilias Kyriopoulos, Giovanni Monti, David Novillo-Ortiz, Ran Milman, Wojciech Wilhelm Zhang-Czabanowski, Greta Nasi, Ariel Dora Stern, George Wharton, and Elias Mossialos. "Digital Health Reimbursement Strategies of 8 European Countries and Israel: Scoping Review and Policy Mapping." e49003. JMIR mHealth and uHealth 11 (2023).